State Stem Cell Agency ICOC Agenda 10/27-8/09

Day 1
Oct 27, 2009
Main Location: 

Luxe Hotel
Sunset Ballroom
11461 Sunset Boulevard
Los Angeles, CA 90049

Additional Locations: 
ValleyCare Health System 5575 West Las Positas Blvd. Suite 300 Pleasanton, CA 94588
Call-in Information: 
Webcast for 10/27 URL :http://65.197.1.15/att/confcast Conference ID: 115708 (No password)
Day 2
Oct 28, 2009
Main Location: 

Luxe Hotel
Sunset Ballroom
11461 Sunset Boulevard
Los Angeles, CA 90049

Additional Locations: 
ValleyCare Health System 5575 West Las Positas Blvd. Suite 300 Pleasanton, CA 94588
Call-in Information: 
Webcast for 10/28 URL :http://65.197.1.15/att/confcast Conference ID: 115709 (No password)

California State Stem Cell Agency

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

1. Call to Order.

2. Pledge of Allegiance.

3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

REPORTS

4. Chairman’s Report.

5. President’s Report.

ACTION ITEMS

6. Consideration of resolutions regarding:
a. Alta Charo, founding member of Standards Working Group; and
b. Don Fisher, CIRM supporter and community leader.

7. Consideration of items relating to the Grants Working Group, including but not limited to:
a. Appointment of new scientific members;
b. Appointment of Co-Vice Chair; and
c. Amendments to the Grants Working Group Bylaws related to the process for appointment and selection of GWG Chairs.

8. Consideration of recommendations from Finance Subcommittee regarding criteria for evaluation of eligibility for recourse loans and process for financial review of loan applications.

9. Consideration of amendment to the Loan Administration Policy, including but not limited to, a proposal to eliminate the requirement that applicants identify whether they would accept a non-recourse loan if they are not eligible for a recourse loan.

10. Consideration of contract for legal services with Nancy J. Koch, J.D.

11. Consideration of recommendations from Grants Working Group on applications for Disease Team Research Awards.

CLOSED SESSION

12. a. Discussion of confidential intellectual property or work product and prepublication, confidential scientific research or data, and financial information relating to applications for Disease Team Research Awards, including grants and loans. (Health & Safety Code 125290.30(d) (3) (B) and (C)).

b. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).

Public report of any action taken, if necessary, during closed session.

*It is expected that the items below this point will occur on October 28, 2009*

ACTION ITEMS

13. Continuation of consideration of recommendations from Grants Working Group on applications for Disease Team Research Awards.

14. Consideration of financial approval of applications for recourse or non-recourse Disease Team Research Award loans.

15. Consideration of Update to Strategic Plan.

16. Consideration of appointment of new member(s) to the Standards Working Group.

17. Consideration of revisions to CIRM Medical and Ethical Standards Regulations Sections 100070, 100080 and 100090.

18. Consideration of travel supplement for CIRM Bridges to Stem Cell Research Awards, RFA 08-04.

DISCUSSION ITEMS

19. Discussion of results of survey of Grants Working Group members regarding public disclosure of financial interests.

20 Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov .

© 2013 California Institute for Regenerative Medicine